By Wendy Van Sickle
Columbus, Ohio, April 22 – GS Finance Corp. priced $25.5 million of 0% autocallable index-linked notes due April 19, 2024 tied to the Nasdaq Biotechnology index and the S&P Biotechnology Select Industry index, according to a 424B2 filing with the Securities and Exchange Commission.
If each index closes at or above its initial level on the April 18, 2022 call observation date, the notes will be called at par plus 15%.
If the notes are not called and each index finishes at or above its initial level, the payout will be par plus 1.3 times the less performing index return.
Otherwise, investors will be exposed to any losses of the lesser-performing index.
The notes are guaranteed by Goldman Sachs Group, Inc.
Goldman Sachs & Co. LLC is the agent.
| Issuer: | GS Finance Corp.
|
| Guarantor: | Goldman Sachs Group, Inc.
|
| Issue: | Autocallable index-linked notes
|
| Underlying indexes: | Nasdaq Biotechnology index, S&P Biotechnology Select Industry index
|
| Amount: | $25.5 million
|
| Maturity: | April 19, 2024
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If the notes are not called and each index finishes at or above its initial level, par plus 1.3 times the lesser-performing index return; full exposure to any loss of lesser-performing index
|
| Call: | If each index closes at or above initial level on April 18, 2022, notes will be called at par plus 15%
|
| Initial index levels: | 4,817.05 for Nasdaq Biotechnology and 10,382.85 for S&P Biotechnology Select
|
| Pricing date: | April 15
|
| Settlement date: | April 20
|
| Agent: | Goldman Sachs & Co. LLC
|
| Fees: | Up to 3.75%
|
| Cusip: | 40057FZT4
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
